Dr. Tiago Reis Marques - 12 May 2025 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Chief Executive Officer, Director
Signature: /s/ Dr. Tiago Reis Marques
Issuer symbol: KTTA
Transactions as of: 12 May 2025
Net transactions value: -$792
Form type: 4
Filing time: 14 May 2025, 21:55:17 UTC
Previous filing: 01 Mar 2024
Next filing: 27 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Marques Tiago	Chief Executive Officer, Director	1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH	/s/ Dr. Tiago Reis Marques	14 May 2025	0001875240

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KTTA	Common Stock	Sale	$792	-960	-2.3%	$0.8250	40,001	12 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person previously held 960 shares of Common Stock of the Issuer in a foreign brokerage account that was recently wound down. As a result, the foreign broker automatically liquidated the Reportion Person's account on May 12, 2025 by selling the 960 shares of Common Stock of the Issuer on a non-discretionary basis.

Remarks:

On January 2, 2024, the Issuer effected a reverse stock split of its Common Stock at a ratio of 1-for-20 (the "Reverse Stock Split"). The number of shares of Common Stock reported herein have been adjusted for the Reverse Stock Split.